Perspective Therapeutics, Inc. (CATX): auditor change — Perspective Therapeutics dismisses auditor Assure CPA, engages Withum

Perspective Therapeutics, Inc.

Audit Committee dismissed Assure CPA, LLC as independent auditor effective April 5, 2024.
Engaged WithumSmith+Brown, PC as new independent auditor for FY 2024, effective same date.
No disagreements with Assure on accounting principles or reportable events during prior periods.
Assure's audit reports for FY 2023, FY 2022, and transition period were unqualified.
Assure provided a letter dated April 8, 2024 concurring with statements, filed as Exhibit 16.1.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Perspective Therapeutics, Inc. engaged WithumSmith+Brown, PC as its auditor.

Action: engagement
Auditor: WithumSmith+Brown, PC

Exact text from the filing

Also, on April 5, 2024, the Audit Committee approved the engagement of WithumSmith+Brown, PC ("Withum") as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, effective immediately

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Perspective Therapeutics, Inc. dismissed Assure CPA, LLC as its auditor.

Action: dismissal
Auditor: Assure CPA, LLC
Successor: WithumSmith+Brown, PC

Exact text from the filing

on April 5, 2024, the Audit Committee approved the dismissal of Assure CPA, LLC ("Assure") as the Company’s independent registered public accounting firm, effective immediately

View on SEC.gov

15 auditor changes filed in the last 30 days. Browse all auditor changes →

Perspective Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-042575

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.